Experience
Regeneron Pharmaceuticals Inc v. Kymab Ltd.*
Regeneron Pharmaceuticals Inc.
Kymab Ltd.
Represented Regeneron against Kymab on patents covering a transgenic mouse platform for antibody discovery in its appeal to the Supreme Court of the United Kingdom.
Regeneron Pharmaceuticals Inc. v. Kymab Ltd., [2020] UKSC 27, Appeal number: UKSC 2018/0131, Supreme Court of the United Kingdom
*Matter handled prior to joining Finnegan.
Warner-Lambert Company LLC
InnoPharma Licensing, Inc.; Lupin Ltd.; and Metrics, Inc. v. Senju Pharmaceuticals Co.
Bausch Health Companies
Mylan Pharmaceuticals Inc. v. Senju Pharmaceutical Co., Ltd.
Senju Pharmaceutical Co., Ltd.; Bausch & Lomb Incorporated
Housey Pharmaceuticals, Inc. v. Otsuka Pharmaceutical Co. Ltd.
Otsuka Pharmaceutical Co. Ltd.
Otsuka Pharmaceutical Co., Ltd. v. Teva Pharmaceuticals USA, Inc.
Otsuka Pharmaceutical Co.
Mylan Pharmaceuticals Inc. v. Bausch Health Ireland Ltd.
Bausch Health Ireland Ltd.
Israel Bio-Engineering Project v. Amgen Inc., et al.
Amgen Inc., Immunex Corp.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.